Brief: Akero Therapeutics Announces Publication Of The Harmony Phase 2B Trial Results
Oct 4 (Reuters) - Akero Therapeutics Inc AKRO.O :
* AKERO THERAPEUTICS ANNOUNCES PUBLICATION OF THE HARMONY
PHASE 2B
TRIAL RESULTS IN THE LANCET GASTROENTEROLOGY & HEPATOLOGY
* AKERO THERAPEUTICS INC - PHASE 3 SYNCHRONY PROGRAM IS ON
TRACK
TO BEGIN ENROLLING BY END OF THIS YEAR
* AKERO THERAPEUTICS INC - THIS MONTH, AKERO PLANS TO REPORT
TOPLINE WEEK 36 RESULTS FROM A SECOND PHASE 2B STUDY
Source text for Eikon: ID:nGNX4RWnqy
Further company coverage: AKRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk